Wyers Mark C, Powell Richard J, Nolan Brian W, Cronenwett Jack L
Section of Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA.
J Vasc Surg. 2007 Feb;45(2):269-75. doi: 10.1016/j.jvs.2006.10.047.
Acute mesenteric ischemia (AMI) caused by arterial occlusive disease requires prompt diagnosis and revascularization to avoid the high mortality associated with this disease. In an attempt to minimize the magnitude of operation for arterial occlusive AMI, we have developed a new technique of endovascular recanalization and open retrograde stenting of the superior mesenteric artery (SMA) during laparotomy so that the bowel can also be assessed and resected if necessary.
All emergent mesenteric revascularizations for arterial occlusive AMI performed at Dartmouth-Hitchcock Medical Center from 2001 to 2005 (n = 13) were retrospectively reviewed. Outcomes were analyzed with respect to the method of revascularization and other perioperative variables. Restenosis was evaluated with duplex ultrasound imaging.
Three different revascularization methods were used: surgical bypass (n = 5), antegrade percutaneous stenting (n = 2), and retrograde open mesenteric (SMA) stenting (ROMS, n = 6). Satisfactory revascularization was achieved in all cases and all methods. ROMS was successfully accomplished in three of six patients after antegrade attempts to cross the SMA from the arm were unsuccessful. At 17%, the ROMS group had the lowest hospital mortality compared with bypass at 80% (P = .08) and percutaneous stent at 100% (P = .11). All five of the surviving patients treated with ROMS were discharged to home after a mean hospital stay of 20 days (range, 6 to 38 days). During a mean follow-up of 13 +/- 7 months, three patients died of unrelated causes, of which two were being followed with asymptomatic recurrent SMA stenosis detected by duplex scan. The two surviving patients are alive and well, but one has required percutaneous SMA stenting of a progressive asymptomatic restenosis.
Retrograde open SMA stenting during laparotomy for AMI has a high technical success rate and provides an attractive alternative to surgical bypass in these often critically ill patients. Because it is combined with open laparotomy, it honors the essential surgical principles of evaluating and resecting nonviable bowel. Restenosis rates appear to be high, so that patients must be followed closely. Further study and development of this new hybrid technique is warranted.
由动脉闭塞性疾病引起的急性肠系膜缺血(AMI)需要迅速诊断并进行血管再通,以避免与该疾病相关的高死亡率。为了尽量减少动脉闭塞性AMI的手术范围,我们开发了一种新的技术,即在剖腹手术期间对肠系膜上动脉(SMA)进行血管腔内再通和开放逆行支架置入,以便在必要时也能评估和切除肠管。
回顾性分析2001年至2005年在达特茅斯-希区柯克医疗中心进行的所有因动脉闭塞性AMI而进行的急诊肠系膜血管再通手术(n = 13)。根据血管再通方法和其他围手术期变量分析结果。通过双功超声成像评估再狭窄情况。
使用了三种不同的血管再通方法:外科搭桥(n = 5)、顺行性经皮支架置入(n = 2)和逆行性开放肠系膜(SMA)支架置入(ROMS,n = 6)。所有病例和所有方法均实现了满意的血管再通。在尝试从手臂顺行穿过SMA未成功后,6例患者中有3例成功完成了ROMS。ROMS组的医院死亡率为17%,相比之下,搭桥组为80%(P = 0.08),经皮支架组为100%(P = 0.11)。接受ROMS治疗的5例存活患者在平均住院20天(范围6至38天)后均出院回家。在平均13±7个月的随访期间,3例患者死于无关原因,其中2例通过双功扫描检测到无症状复发性SMA狭窄正在接受随访。2例存活患者情况良好,但其中1例因进行性无症状再狭窄需要进行经皮SMA支架置入。
在剖腹手术期间对AMI进行逆行性开放SMA支架置入具有较高的技术成功率,为这些通常病情危重的患者提供了一种有吸引力的替代外科搭桥的方法。由于它与开放剖腹手术相结合,它遵循了评估和切除无活力肠管的基本外科原则。再狭窄率似乎较高,因此必须密切随访患者。这种新的混合技术值得进一步研究和开发。